There is not enough applicable seb derm evidence to give cosmetic Papain a clear general recommendation. Its conditioning functions do not establish a treatment effect, and reported allergy concerns should remain tied to the preparations and exposures studied.

FDA action concerned unapproved papain-containing topical drugs used for wound care, including reported hypersensitivity; that scope does not become an unconditional cosmetic ban. An older seborrheic-alopecia report and occupational-allergy records were located without usable abstracts, so no outcomes are inferred from their titles. Consider the whole product and known allergies, and ask a clinician or pharmacist about persistent irritation.